# RGS12

## Overview
RGS12, or Regulator of G protein signaling 12, is a gene that encodes a multifunctional scaffold protein involved in various cellular signaling pathways. The RGS12 protein is categorized as a scaffold protein due to its ability to facilitate the assembly of multiprotein complexes, particularly in the Ras/Raf/MEK/ERK signaling pathway, which is crucial for neuronal differentiation and skeletal muscle development (Willard2007Selective; Schroer2019A). It contains several domains, including a conserved RGS domain, PDZ domain, and GoLoco domain, which enable it to modulate G protein-coupled receptor (GPCR) signaling and interact with a variety of proteins (AbramowNewerly2006RGS; Hepler1999Emerging). RGS12 is implicated in the regulation of myoblast proliferation and differentiation, mitochondrial function, and has been associated with diseases such as inflammatory arthritis and certain cancers, where it can act as either a tumor suppressor or an activator of inflammatory pathways (Li2021RGS12; Yuan2020RGS12).

## Structure
The RGS12 protein is characterized by a complex molecular structure that includes several distinct domains and splice variant isoforms. It contains a conserved RGS domain, which is crucial for its role in accelerating GTPase activity, thereby modulating G protein signaling (Hepler1999Emerging). RGS12 also features a PDZ domain, which facilitates interactions with the C terminus of interleukin-8 receptor B (CXCR2) and potentially other GPCRs, highlighting its role in specific protein-protein interactions (AbramowNewerly2006RGS; Hepler1999Emerging). 

The protein exists in multiple splice variants, resulting in diverse isoforms with varying N- and C-terminal domains. These variants include RGS12B, RGS12P, RGS12L, and RGS12TS, each with unique structural features and tissue-specific expression patterns (Chatterjee2000Novel). The RGS12TS variant is particularly notable for its trans-splicing mechanism, which is rare among genes (Chatterjee2000Novel). 

RGS12 proteins are primarily localized in the nucleus, with some variants, like RGS12TS-S, showing a unique dotted distribution pattern, suggesting specialized nuclear functions (Chatterjee2000Novel). The protein's structure is further complicated by the presence of additional domains, such as a phosphotyrosine-binding domain and a guanylyl nucleotide exchange factor domain, which may contribute to its interactions and regulatory roles (Chatterjee2000Novel).

## Function
RGS12 (Regulator of G protein signaling 12) functions as a scaffold protein in the Ras/Raf/MEK/ERK signaling pathway, playing a crucial role in nerve growth factor (NGF)-mediated differentiation. It interacts with key components such as H-Ras, B-Raf, and MEK2, facilitating the assembly of a multiprotein complex that enhances ERK activation, which is essential for neurite outgrowth and axonal growth in neurons (Willard2007Selective). RGS12's role as a scaffold is supported by its multiple domains, including Ras-binding, PDZ, and phosphotyrosine-binding domains, which enable it to coordinate signaling pathways and promote neuronal differentiation (Willard2007Selective).

In skeletal muscle development, RGS12 regulates myoblast proliferation and differentiation. It is expressed in developing muscle tissues and is crucial for muscle regeneration following injury. Myoblasts lacking RGS12 show impaired differentiation into myotubes, indicating its role in balancing proliferation and differentiation (Schroer2019A).

RGS12 is also involved in maintaining mitochondrial function during skeletal development. It enhances ATP synthase activity by promoting tyrosine phosphorylation of ATP5A, which is vital for energy production and cellular homeostasis (Yuan2020RGS12).

## Clinical Significance
Alterations in the expression of the RGS12 gene have been implicated in several diseases, particularly inflammatory arthritis and various cancers. In rheumatoid arthritis (RA), RGS12 is upregulated and acts as a critical activator of the NF-kB signaling pathway, which is essential for the transcriptional regulation of inflammatory cytokines. This upregulation contributes to the pathogenesis of RA by promoting inflammation through an RGS12-NF-kB positive feedback loop, enhancing NF-kB nuclear translocation and phosphorylation (Yuan2020RGS12).

In osteosarcoma, RGS12 functions as a tumor suppressor. Its expression is markedly decreased in both human and mouse osteosarcoma specimens, correlating with increased tumor severity. RGS12 negatively regulates the YAP/TEAD1-Ezrin signaling pathway, which is crucial for tumor progression and metastasis. Loss of RGS12 leads to increased cell proliferation, migration, and invasion, suggesting its potential as a therapeutic target in osteosarcoma (Li2021RGS12).

In oral squamous cell carcinoma (OSCC), RGS12 is also downregulated and acts as a tumor suppressor by interacting with PTEN to inactivate the AKT/mTOR signaling pathway, thereby inhibiting cancer cell proliferation and migration. This suggests that RGS12 could serve as a prognostic biomarker and therapeutic target for OSCC (Fu2020RGS12).

## Interactions
RGS12 interacts with various proteins and plays a significant role in G protein-coupled receptor (GPCR) signaling pathways. It contains a unique N-terminal PDZ domain that specifically binds to a PDZ binding motif on the interleukin 8B (IL-8B or CXCR2) receptor, suggesting that RGS12 can associate with specific receptors in living systems (Hepler1999Emerging). This interaction is unique to RGS12 among its family members, as it binds with high affinity to a four amino acid PDZ binding motif (STTL) at the IL-8B tail (Hepler1999Emerging).

RGS12 also contains a GoLoco domain, which provides a second Gα binding region, allowing it to potentially bind simultaneously to two G proteins within a signaling complex containing multiple GPCRs and G proteins (AbramowNewerly2006RGS). In neurons, RGS12 interacts with the SNARE-binding region of the α1-subunit of the N-type calcium channel, a region that is tyrosine-phosphorylated in response to GABA B receptor stimulation. This interaction suggests a competitive binding scenario with syntaxin, which is crucial for the stabilization of Gβγ subunit binding (AbramowNewerly2006RGS). These interactions highlight RGS12's role in complex signaling pathways and its potential regulatory functions.


## References


[1. (Li2021RGS12) Yang Li, Min Liu, Shuting Yang, Ashley M. Fuller, T. S. Karin Eisinger-Mathason, and Shuying Yang. Rgs12 is a novel tumor suppressor in osteosarcoma that inhibits yap-tead1-ezrin signaling. Oncogene, 40(14):2553–2566, March 2021. URL: http://dx.doi.org/10.1038/s41388-020-01599-z, doi:10.1038/s41388-020-01599-z. This article has 19 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/s41388-020-01599-z)

[2. (Hepler1999Emerging) John R Hepler. Emerging roles for rgs proteins in cell signalling. Trends in Pharmacological Sciences, 20(9):376–382, September 1999. URL: http://dx.doi.org/10.1016/s0165-6147(99)01369-3, doi:10.1016/s0165-6147(99)01369-3. This article has 209 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/s0165-6147(99)01369-3)

[3. (AbramowNewerly2006RGS) Maria Abramow-Newerly, Anju A. Roy, Caroline Nunn, and Peter Chidiac. Rgs proteins have a signalling complex: interactions between rgs proteins and gpcrs, effectors, and auxiliary proteins. Cellular Signalling, 18(5):579–591, May 2006. URL: http://dx.doi.org/10.1016/J.CELLSIG.2005.08.010, doi:10.1016/j.cellsig.2005.08.010. This article has 300 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/J.CELLSIG.2005.08.010)

[4. (Schroer2019A) Adam B. Schroer, Junaith S. Mohamed, Melinda D. Willard, Vincent Setola, Emily Oestreich, and David P. Siderovski. A role for regulator of g protein signaling-12 (rgs12) in the balance between myoblast proliferation and differentiation. PLOS ONE, 14(8):e0216167, August 2019. URL: http://dx.doi.org/10.1371/journal.pone.0216167, doi:10.1371/journal.pone.0216167. This article has 10 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0216167)

[5. (Chatterjee2000Novel) Tapan K. Chatterjee and Rory A. Fisher. Novel alternative splicing and nuclear localization of humanrgs12 gene products. Journal of Biological Chemistry, 275(38):29660–29671, September 2000. URL: http://dx.doi.org/10.1074/jbc.m000330200, doi:10.1074/jbc.m000330200. This article has 61 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m000330200)

[6. (Fu2020RGS12) C. Fu, G. Yuan, S.T. Yang, D. Zhang, and S. Yang. Rgs12 represses oral cancer via the phosphorylation and sumoylation of pten. Journal of Dental Research, 100(5):522–531, November 2020. URL: http://dx.doi.org/10.1177/0022034520972095, doi:10.1177/0022034520972095. This article has 40 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1177/0022034520972095)

[7. (Willard2007Selective) Melinda D Willard, Francis S Willard, Xiaoyan Li, Steven D Cappell, William D Snider, and David P Siderovski. Selective role for rgs12 as a ras/raf/mek scaffold in nerve growth factor-mediated differentiation. The EMBO Journal, 26(8):2029–2040, March 2007. URL: http://dx.doi.org/10.1038/sj.emboj.7601659, doi:10.1038/sj.emboj.7601659. This article has 61 citations.](https://doi.org/10.1038/sj.emboj.7601659)

[8. (Yuan2020RGS12) Gongsheng Yuan, Shuting Yang, Andrew Ng, Chuanyun Fu, Merry Jo Oursler, Lianping Xing, and Shuying Yang. Rgs12 is a novel critical nf-κb activator in inflammatory arthritis. iScience, 23(6):101172, June 2020. URL: http://dx.doi.org/10.1016/j.isci.2020.101172, doi:10.1016/j.isci.2020.101172. This article has 37 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.isci.2020.101172)